| 000 | 01559 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511201953.0 | ||
| 264 | 0 | _c19920109 | |
| 008 | 199201s 0 0 eng d | ||
| 022 | _a0147-8389 | ||
| 024 | 7 |
_a10.1111/j.1540-8159.1991.tb02879.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWare, D L | |
| 245 | 0 | 0 |
_aIntravenous 3-methoxy-O-desmethyl-encainide in reentrant supraventricular tachycardia: a randomized double-blind placebo-controlled trial in patients undergoing EP study. _h[electronic resource] |
| 260 |
_bPacing and clinical electrophysiology : PACE _cSep 1991 |
||
| 300 |
_a1343-50 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCardiac Pacing, Artificial |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 |
_aEncainide _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aTachycardia, Supraventricular _xdiagnosis |
| 700 | 1 | _aLee, J T | |
| 700 | 1 | _aMurray, K T | |
| 700 | 1 | _aHanyok, J J | |
| 700 | 1 | _aRoden, D M | |
| 700 | 1 | _aEcht, D S | |
| 773 | 0 |
_tPacing and clinical electrophysiology : PACE _gvol. 14 _gno. 9 _gp. 1343-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1540-8159.1991.tb02879.x _zAvailable from publisher's website |
| 999 |
_c1726927 _d1726927 |
||